Improvement of verbal behavior after pharmacological treatment of developmental stuttering: a case study
暂无分享,去创建一个
Michele Grassi | Alessandro Tavano | Pierpaolo Busan | Franco Fabbro | Giovanna Pelamatti | F. Fabbro | P. Busan | A. Tavano | G. Pelamatti | M. Grassi
[1] P Howell,et al. Exchange of stuttering from function words to content words with age. , 1999, Journal of speech, language, and hearing research : JSLHR.
[2] J. Wu,et al. Increased dopamine activity associated with stuttering , 1997, Neuroreport.
[3] G. Riley,et al. A neurological basis of stuttering? , 2002, The Lancet Neurology.
[4] L A Gottschalk,et al. Risperidone for the treatment of stuttering. , 2000, Journal of clinical psychopharmacology.
[5] N J Cox,et al. The genetic basis of persistence and recovery in stuttering. , 1997, Journal of speech, language, and hearing research : JSLHR.
[6] E. Yairi,et al. Genetics of stuttering: a critical review. , 1996, Journal of speech and hearing research.
[7] S B Leder. Adult onset of stuttering as a presenting sign in a parkinsonian-like syndrome: a case report. , 1996, Journal of communication disorders.
[8] Tim J Anderson,et al. Tics and developmental stuttering. , 2003, Parkinsonism & related disorders.
[9] R. Kroll,et al. Stuttering: an update for physicians. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[10] R E Carson,et al. Altered patterns of cerebral activity during speech and language production in developmental stuttering. An H2(15)O positron emission tomography study. , 1997, Brain : a journal of neurology.
[11] Gerald Maguire,et al. Management of Child and Adolescent Stuttering with Olanzapine: Three Case Reports , 1999, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[12] H. Dorn,et al. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death. Vol. I , 1950 .
[13] B. Schneider. MANUAL of the international statistical classification of diseases, injuries, and causes of death. Addendum 1. Supplementary interpretations and instructions for coding causes of death. , 1953, Bulletin of the World Health Organization. Supplement.
[14] S. Schreiber,et al. Paroxetine for secondary stuttering: further interaction of serotonin and dopamine. , 1997, The Journal of nervous and mental disease.
[15] Frank Wijnen,et al. Stuttering and speech monitoring , 2001, DiSS.